DrugPatentWatch Database Preview
Drugs in Development Information for Sulopenem
Email this page to a colleague
What is the development status for investigational drug Sulopenem?
Sulopenem is an investigational drug.
There have been 6 clinical trials for Sulopenem.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2018.
The most common disease conditions in clinical trials are Infection, Communicable Diseases, and Urinary Tract Infections. The leading clinical trial sponsors are Iterum Therapeutics, US Limited, Pfizer, and Iterum Therapeutics, International Limited.
There are two hundred and thirty US patents protecting this investigational drug and one international patent.
Summary for Sulopenem
| US Patents | 230 |
| International Patents | 1,165 |
| US Patent Applications | 782 |
| WIPO Patent Applications | 290 |
| Japanese Patent Applications | 61 |
| Clinical Trial Progress | Phase 2 (2018-08-01) |
| Vendors | 23 |
Recent Clinical Trials for Sulopenem
| Title | Sponsor | Phase |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents | Iterum Therapeutics, International Limited | Phase 1 |
| Oral Sulopenem Etzadroxil With Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women | Iterum Therapeutics, US Limited | Phase 3 |
| Sulopenem and Sulopenem Etzadroxil With Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults | Iterum Therapeutics, US Limited | Phase 3 |
Clinical Trial Summary for Sulopenem
Top disease conditions for Sulopenem
Top clinical trial sponsors for Sulopenem
US Patents for Sulopenem
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sulopenem | Get Started Free | Methods of treating inflammation associated airway diseases and viral infections | WASHINGTON STATE UNIVERSITY (Pullman, WA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX) | Get Started Free |
| Sulopenem | Get Started Free | Use of gelsolin to treat infections | The Brigham and Women's Hospital, Inc. (Boston, MA) | Get Started Free |
| Sulopenem | Get Started Free | Compositions and methods for delivering an agent to a wound | UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION (Memphis, TN) | Get Started Free |
| Sulopenem | Get Started Free | Oral appliance for delivering a medicament | Get Started Free | |
| Sulopenem | Get Started Free | Genetically engineered swine influenza virus and uses thereof | Icahn School of Medicine at Mount Sinai (New York, NY) St. Jude Children's Research Hospital (Memphis, TN) The United States of America, As Represented by the Secretary of Agriculture (Washington, DC) | Get Started Free |
| Sulopenem | Get Started Free | Method for using novel hydroxamic acid derivative and antibacterial substance in combination | TOYAMA CHEMICAL CO., LTD. (Shinjuku-ku, JP) | Get Started Free |
| Sulopenem | Get Started Free | Pharmaceutical agents and methods relating thereto | Cushing Academy (Ashburnham, MA) | Get Started Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sulopenem
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sulopenem | Australia | AU2005244865 | 2024-05-12 | Get Started Free |
| Sulopenem | Canada | CA2607686 | 2024-05-12 | Get Started Free |
| Sulopenem | Canada | CA2860173 | 2024-05-12 | Get Started Free |
| Sulopenem | China | CN1980694 | 2024-05-12 | Get Started Free |
| Sulopenem | Denmark | DK1755661 | 2024-05-12 | Get Started Free |
| Sulopenem | European Patent Office | EP1755661 | 2024-05-12 | Get Started Free |
| Sulopenem | European Patent Office | EP2335722 | 2024-05-12 | Get Started Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
